Skip to content
Disclosery

PharVision Advisers, LLC: MLCO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of PharVision Advisers, LLC on MLCO, newest first. How the timeline and the estimate are built.

PharVision Advisers, LLC held 15,509 MLCO shares at 2026-06-30 per its 13F-HR filed 2026-08-11.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 15,509 shares
    Change vs previous 13F -19,563 shares

    1.54% of the 13F portfolio, value $81,732.

    13F-HR 0001420506-26-001505 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F/A 35,072 shares
    Change vs previous 13F -27,604 shares

    2.02% of the 13F portfolio, value $199,209.

    13F-HR/A 0001420506-26-000909 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 62,676 shares
    Change vs previous 13F +18,381 shares

    0.24% of the 13F portfolio, value $474,457.

    13F-HR 0001420506-26-000567 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 44,295 shares
    Change vs previous 13F not available

    0.23% of the 13F portfolio, value $406,185.

    13F-HR 0001420506-25-003453 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).